Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice
Rejuvenation Research · 2023
DOI: 10.1089/rej.2022.0063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rejuvenation Research, 2023. Verfasst von Yu-Min Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou China. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Alzheimer's disease (AD) is the most common type of dementia with an insidious onset and slow progression. Kai-Xin-San (KXS) has been reported to be effective in improving cognitive impairment in AD. However, the mechanism is still confused. In this study, we employed APP/PS1 mice to explore the neuroprotective mechanism of KXS. Forty-eight male APP/PS1 mice were randomly divided into model group, KXS groups (0.7, 1.4, and 2.8 g/kg/d, p.o.) and the wild-type mice were assigned to the normal control group ( n = 12 in each group). Y-maze and novel object recognition tests were carried out after continuous intragastric administration for 2 months. The abilities of learning, memory, and new object recognition in the APP/PS1 mice were enhanced significantly after KXS treatment. KXS can reduce the deposition of Aβ 40 and Aβ 42 in APP/PS1 mice brain. KXS decreased the levels of serum inflammatory cytokines, tumor necrosis factor-α, interleukin-1β, and interleukin-6. KXS increased the activities of superoxide dismutase and glutathione peroxidase significantly, whereas it inhibited the contents of reactive oxygen species and malondialdehyde significantly. In addition, we also detected Wnt/β-catenin signaling related proteins, such as Wnt7a, β-catenin, low-density lipoprotein receptor-related protein 6 (LRP6), glycogen synthase kinase-3β (GSK-3β), nuclear factor kappa-B (NF-κB), postsynaptic density 95 (PSD95), microtubule associated protein-2 (MAP-2), and endoplasmic reticulum stress (IRE1 pathway) related proteins, such as inositol-requiring enzyme 1 (IRE1), phosphorylated IRE1(p-IRE1), spliced X-box-binding protein 1 (XBP1s), immunoglobulin binding protein (BIP), and protein disulfide isomerase (PDI) in the hippocampus. Results showed that KXS decreased the expression of GSK-3β, NF-kB, p-IRE1/IRE1 ratio, XBP1s, and BIP; increased the expression of Wnt7a, β-catenin, LRP6, PSD95, MAP2, and PDI. In conclusion, KXS improved cognitive impairment by activating Wnt/β-catenin signaling, inhibiting the IRE1/XBP1s pathway in APP/PS1 mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou China.
- Henan University of Chinese Medicine, Zhengzhou, China.
- The Affiliated TCM Hospital of Guangzhou Medical University, Guangzhou, China.
- Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Zitieren
APA
Xu, Y. M., Lu, F. M., Xu, H. C., Zhang, J., Hei, S. Y., Qiu, Y. H., Cai, Y. F., Zhang, S. J., & Zhao, M. (2023). Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice. Rejuvenation Research. https://doi.org/10.1089/rej.2022.0063
Vancouver
Xu YM, Lu FM, Xu HC, Zhang J, Hei SY, Qiu YH, et al. Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice. Rejuvenation Research. 2023. doi:10.1089/rej.2022.0063
BibTeX
@article{Xu2023,
author = {Xu, Yu-Min and Lu, Fang-Mei and Xu, Hong-Cai and Zhang, Jie and Hei, Shang-Yan and Qiu, Yu-Hui and Cai, Ye-Feng and Zhang, Shi-Jie and Zhao, Min},
title = {Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice},
journal = {Rejuvenation Research},
year = {2023},
doi = {10.1089/rej.2022.0063}
}
EUVIMED